IHT Wealth Management’s Cabaletta Bio CABA Stock Holding History

IHT Wealth Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,240	Closed	-$13K	–	874
2022 Q2	$13K	Hold	12,240	–	–	﹤0.01%	728
2022 Q1	$25K	Sell	12,240 -150	-1%	-$392	﹤0.01%	755
2021 Q4	$47K	Sell	12,390 -675	-5%	-$7.2K	﹤0.01%	787
2021 Q3	$159K	Sell	13,065 -150	-1%	-$1.38K	0.01%	756
2021 Q2	$114K	Buy	+13,215	New	+$130K	0.01%	903

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

IHT Wealth Management's CABA Position: Q3 2022 in Review

IHT Wealth Management sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 12,240 shares — an estimated $13K sold.

IHT Wealth Management first reported a position in CABA in Q2 2021 and held it in 5 quarters. The position peaked at $159K in Q3 2021. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

IHT Wealth Management reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
IHT Wealth Management sold 12,240 Cabaletta Bio shares in Q3 2022, an estimated $13K.
IHT Wealth Management first reported a position in Cabaletta Bio in Q2 2021 and held it in 5 quarters.
IHT Wealth Management's Cabaletta Bio position peaked at $159K in Q3 2021.
54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on IHT Wealth Management's 13F filing for Q3 2022, filed 22 Nov 2022.